Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that suppress T cells and found that supplementing with UDCA reversed the effect, controlling tumor growth in mice. Since UDCA is already used for liver disease, it could quickly translate into clinical trials.
from Top Health News -- ScienceDaily https://ift.tt/M17r6Op
Subscribe to:
Post Comments (Atom)
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
At least 22 people were killed and 171 others injured on Sunday when one of Taiwan’s newer, faster trains derailed on a curve along a popula...
-
Prosecutors in Mexico have opened an investigation into former president Enrique Peña Nieto, who is accused of taking bribes in one of Latin...
No comments:
Post a Comment